You are about to leave DOPTELET.com/itp and go to an external page.
Please note that Sobi, Inc. is not responsible for the content of the website you are
about to visit.
Go back
You are about to leave DOPTELET.com/itp and go to an external page.
Please note that Sobi, Inc. is not responsible for the content of the website you are
about to visit.
Go back
Discover the Doptelet Copay
Assistance Program
Terms and Conditions
If you miss your dose of Doptelet, take it as soon as you remember. Don’t take 2 doses at once to make up for missing a dose. You should take your next dose at your usual time.
If you think you’ve taken more Doptelet than you were prescribed, call your doctor or go to the nearest emergency room right away.
Everyone’s treatment goals are different, so it’s important to keep taking Doptelet exactly as your doctor prescribed, based on the treatment plan you agreed on together. If you have questions about how long you’ll be on Doptelet, talk to your doctor or care team—they’re there to help.
The cost of Doptelet may vary depending on your insurance. Eligible patients who have commercial insurance may pay as little as $0 with the Doptelet Copay Assistance Program. Find out if you’re eligible.
Doptelet Connect also has dedicated Case Managers who can help research your individual coverage, coordinate with a pharmacy to fill your prescription, and connect you with copay assistance or free product, if needed. Learn more.
Yes. 49 patients living with chronic ITP were studied in a 6-month clinical trial for Doptelet. Some were taking Doptelet, some weren’t. On Day 8 of the trial, 21 out of the 32 patients taking Doptelet reached at least 50,000 platelets per microliter or more. Those not on Doptelet didn’t reach 50,000 platelets per microliter. Beyond that, the patients taking Doptelet were able to keep their platelet counts at 50,000 platelets per microliter or higher for an average of 12 total weeks vs 0 weeks for those not on Doptelet.
No, Doptelet isn’t a steroid. It’s a thrombopoietin receptor agonist (TPO-RA) that can help lift your platelet count.
With Doptelet, you have full food freedom, meaning you can eat any food you want, whenever you want. This includes calcium- and magnesium-rich foods.
Doptelet is the only oral thrombopoietin receptor agonist (TPO-RA) that helps lift your platelet count on your ideal schedule with no food-type restrictions, additional liver monitoring, or injections.
Friendly reminder: Food’s a must when taking your dose of Doptelet, but which kind is up to you. When you start on Doptelet, your doctor will check your platelet count with a weekly blood test. Once you’ve reached your treatment goal, they’ll check it monthly.
Discover why Doptelet can be the right ITP treatment option for you.
The most common side effects of Doptelet are headache, tiredness, bruising, nosebleed, upper respiratory tract infection, joint pain, gum bleeding, purple or red spots on your skin (petechiae), and runny nose. Doptelet is a thrombopoietin receptor agonist (TPO-RA) and TPO-RAs have been associated with blood clots. Tell your doctor right away if you have symptoms of a blood clot, including: swelling, pain, or tenderness in your legs, shortness of breath, chest pain, fast heartbeat, and stomach (abdominal) pain or tenderness.
Meet Tammy, our Dopteller (aka patient ambassador). You can watch her talk about life after diagnosis, reaching her goals, why Doptelet works for her, and more here.
While everyone’s treatment goal is unique (based on their age, medical history, activity level, etc), for most people, keeping a count of 50,000 platelets per microliter or more can help reduce risk.
Talk to your doctor to figure out what your treatment goals should be.
It’s important to know and remember that the goal of treatment may not be to normalize your platelet counts. Everyone’s platelet count goal is unique, so it’s up to you and your doctor to set and reach your goals together.
A normal platelet count in adults ranges from 150,000 to 450,000 platelets per microliter of blood, but for most people keeping a count of 50,000 platelets per microliter or more can help reduce risk.
INDICATION & IMPORTANT SAFETY INFORMATION
What is DOPTELET (avatrombopag)?
DOPTELET is a prescription medicine used to help treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough. It is not known if DOPTELET is safe or works in children.
Who should not receive DOPTELET?
You should not receive DOPTELET if you have ever had a blood clot, are pregnant, plan to become pregnant or plan to breastfeed. It is not known if DOPTELET passes into breast milk or if DOPTELET may have unintended side effects for your unborn baby. Do not breastfeed during your treatment with DOPTELET and for at least 2 weeks after the last dose.
You should call your healthcare provider or get medical help right away if you have any of the signs or symptoms of a blood clot after getting DOPTELET. They can be life threatening or cause death.
Before taking DOPTELET, you should tell your healthcare provider about all your medical conditions and medicines including vitamins, supplements, and herbal remedies.
What are the possible side effects of DOPTELET?
For patients with chronic ITP, the most common side effects are headache, fatigue, bruising, nosebleeds, upper respiratory tract infection, joint pain, bleeding gums, purple or red spots on your skin (petechiae), and runny nose.
You Should Know: These are not all of the possible side effects for DOPTELET. For more information, ask your healthcare provider or review the Prescribing Information at https://www.doptelet.com/doptelet.pdf.
If you suspect that you have experienced a side effect, call your healthcare provider. You may also report them to the US Food and Drug Administration (FDA) at 1-800-FDA-1088.
For further information, please see full Prescribing Information, including the Patient Information Leaflet.
What is DOPTELET® (avatrombopag)?
DOPTELET is a prescription medicine used to help treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough. It is not known if DOPTELET is safe or works in children.
Who should not receive DOPTELET?
You should not receive DOPTELET if you have ever had a blood clot, are pregnant, plan to become pregnant or plan to breastfeed. It is not known if DOPTELET
What is DOPTELET (avatrombopag)?
DOPTELET is a prescription medicine used to help treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough. It is not known if DOPTELET is safe or works in children.
Who should not receive DOPTELET?
You should not receive DOPTELET if you have ever had a blood clot, are pregnant, plan to become pregnant or plan to breastfeed. It is not known if DOPTELET passes into breast milk or if DOPTELET may have unintended side effects for your unborn baby. Do not breastfeed during your treatment with DOPTELET and for at least 2 weeks after the last dose.
You should call your healthcare provider or get medical help right away if you have any of the signs or symptoms of a blood clot after getting DOPTELET. They can be life threatening or cause death.
Before taking DOPTELET, you should tell your healthcare provider about all your medical conditions and medicines including vitamins, supplements, and herbal remedies.
What are the possible side effects of DOPTELET?
For patients with chronic ITP, the most common side effects are headache, fatigue, bruising, nosebleeds, upper respiratory tract infection, joint pain, bleeding gums, purple or red spots on your skin (petechiae), and runny nose.
You Should Know: These are not all of the possible side effects for DOPTELET. For more information, ask your healthcare provider or review the Prescribing Information at https://www.doptelet.com/doptelet.pdf.
If you suspect that you have experienced a side effect, call your healthcare provider. You may also report them to the US Food and Drug Administration (FDA) at 1-800-FDA-1088.
For further information, please see full Prescribing Information, including the Patient Information Leaflet.
This website uses cookies. By continuing to
use this website, you consent to our use of these cookies. Read more about our use of cookies